ASCENDIS HEALTH LIMITED - Notification in terms of section 122(3) of the Companies Act and section 3.83(b) of the JSE Listings Requirements

Notification in terms of section 122(3) of the Companies Act and section 3.83(b) of the JSE Listings Requirements

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis”)


NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND SECTION 3.83(b) OF
THE JSE LISTINGS REQUIREMENTS


In accordance with section 122(3)(b) of the Companies Act, 71 of 2008 ("the Act"), and section 3.83(b)
of the JSE Listings Requirements, holders of ordinary shares in Ascendis are advised that Mergence
Investment Managers, on behalf of its clients, has acquired Ascendis ordinary shares, such that their
beneficial interest in Ascendis now amounts to 5.07% of the total number of shares in issue.

Ascendis hereby confirms that it has received the required notice from Mergence Investment
Managers, on behalf of its clients, in terms of section 122(1) of the Act. As required in terms of section
122(3) (a) of the Act, Ascendis has filed the required notice with the Takeover Regulation Panel.


Bryanston
13 February 2019

Sponsor
Questco Corporate Advisory (Proprietary) Limited

Date: 13/02/2019 05:09:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.